Novo

Money

Novo Nordisk Stock Jumps on Early Stage Weight-Loss Drug Trial Results

KEY TAKEAWAYS Novo Nordisk’s U.S.-listed shares are surging 9% Friday morning after the Danish drugmaker reported early stage results for…

Read More »
Money

Novo Nordisk Sinks on Disappointing Trial Results for Next Gen Weight Loss Drug

Key Takeaways Novo Nordisk’s U.S.-listed shares tumbled over 19% Friday morning after it released data from a new weight loss…

Read More »
Money

Eli Lilly, Novo Nordisk Stocks Gain as Biden Moves to Expand Coverage of Weight-Loss Drugs

Key Takeaways Eli Lilly and Novo Nordisk shares rose Tuesday after the Biden administration proposed expanding coverage of the companies’…

Read More »
Money

Novo Nordisk Stock Rises on Earnings Beat, Narrowed Outlook

Key Takeaways Novo Nordisk’s U.S.-listed shares rose Wednesday morning as third-quarter profits beat estimates and sales of Ozempic and Wegovy…

Read More »
Money

Hims Reports Strong Earnings, Novo Nordisk Copycat Drug Coming in 2025

Key Takeaways Hims’ third-quarter results topped expectations, driven in part by revenue from its weight-loss drugs. The company said it…

Read More »
Money

What Wall Street Analysts Think of Novo Nordisk’s Stock Ahead of Earnings

Key Takeaways Danish pharmaceutical giant Novo Nordisk is set to report earnings for the third quarter of 2024 on Wednesday…

Read More »
Health

Elucidating the mechanism underlying de novo membrane formation during gametogenesis

Sexual reproduction, a common mode of reproduction among numerous species, involves gametogenesis in which offspring are produced through fertilization, conjugation,…

Read More »
Money

Novo Nordisk Stock Slips as CEO Faces Senate Inquiry Into Wegovy, Ozempic Prices

Key Takeaways Novo Nordisk CEO Lars Fruergaard Jorgensen will testify Tuesday before a Senate panel looking into the drug maker’s…

Read More »
Money

Novo Nordisk Sinks on Obesity Drug Study’s Disappointing Results

Key Takeaways Novo Nordisk’s U.S.-listed shares lost ground Friday after a Phase 2a trial of the pharmaceutical firm’s latest obesity…

Read More »
Money

What You Need To Know Ahead of Novo Nordisk Earnings Wednesday

<img src='https://www.investopedia.com/thmb/AIq_avuLkl5zDDidl7t0N1Y3JP0=/filters:no_upscale():max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1690265028-388edef8c47f4184bfba3e5deda32f0c.jpg' alt=' Christian Schultz / picture alliance / Getty Images ‘ title=”Novo Nordisk logo on office building”> Christian Schultz…

Read More »
Back to top button